Honghai Guo

the third department of surgery

H指数:18

被引数:858

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and feasibility of robot-assisted remote radical gastrectomy for gastric cancer based on 5G communication technology (FUTURE-04): a prospective, single-arm clinical trial

基于5G通信技术的机器人辅助远程根治性胃切除术安全性及可行性研究（FUTURE-04）：一项前瞻性、单臂临床试验

Gastric Cancer

IF5.1

2025-11-180

PRE

Association of low skeletal muscle mass and radiodensity with clinical outcomes in patients undergoing robotic radical gastric cancer surgery: a population-based retrospective cohort study

BMC CANCER

IF3.4

2025-04-210

OAAI

Preoperative sarcopenia and postoperative accelerated muscle loss negatively impact survival after resection of locally advanced gastric cancer

BMC CANCER

IF3.4

2025-02-140

OAAI

Preoperative liquid biopsy transcriptomic panel for risk assessment of lymph node metastasis in T1 gastric cancer

T1期胃癌淋巴结转移风险评估的术前液体活检转录组学检测方案

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2025-02-070

Combined systemic inflammatory immune index and prognostic nutrition index as chemosensitivity and prognostic markers for locally advanced gastric cancer receiving neoadjuvant chemotherapy: a retrospective study

联合全身炎症免疫指标和预后营养指标作为局部进展期胃癌新辅助化疗化疗敏感性和预后指标的回顾性研究

BMC CANCER

IF3.4

2024-08-153

OAAI

N6-methyladenosine modified circPAK2 promotes lymph node metastasis via targeting IGF2BPs/VEGFA signaling in gastric cancer

N6-methyladenosine修饰的circPAK2通过靶向IGF2BPs/VEGFA信号促进胃癌淋巴结转移

ONCOGENE

IF7.3

2024-07-170

PRE

Impact of preoperative sarcopenia on postoperative complications and prognosis in patients undergoing robotic gastric cancer surgery: A propensity score matching study

术前肌肉减少对机器人胃癌手术患者术后并发症及预后的影响: 一项倾向评分匹配研究

NUTRITION

IF3

2024-07-016

PRE

MicroRNA-431-5p inhibits angiogenesis, lymphangiogenesis, and lymph node metastasis by affecting TGF-β1/SMAD2/3 signaling via ZEB1 in gastric cancer

MOLECULAR CARCINOGENESIS

IF3.2

2024-04-244

PRE

Myosteatosis predicts postoperative complications and long-term survival in robotic gastrectomy for gastric cancer: A propensity score analysis

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

IF3.6

2024-03-272

PRE

Study protocol of a phase II clinical trial evaluating the efficacy of neoadjuvant intraperitoneal and systemic albumin-bound paclitaxel combined with camrelizumab and S-1 in the treatment of patients with exfoliative cell-positive gastric cancer

FRONTIERS IN ONCOLOGY

IF3.3

2023-09-291

OAAI

Neoadjuvant docetaxel, oxaliplatin plus capecitabine versus oxaliplatin plus capecitabine for patients with locally advanced gastric adenocarcinoma: long-term results of a phase III randomized controlled trial

INTERNATIONAL JOURNAL OF SURGERY

IF10.1

2023-09-045

OAAI

Comment on 'Hand grip strength-based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer' by Xie et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE

IF9.1

2023-07-280

OAAI

Sarcopenia: Molecular regulatory network for loss of muscle mass and function

FRONTIERS IN NUTRITION

IF5.1

2023-02-0223

OAAI

The safety and efficacy of carbon nanoparticle suspension injection versus indocyanine green tracer-guided lymph node dissection during radical gastrectomy (FUTURE-01): A single-center randomized controlled trial protocol

FRONTIERS IN ONCOLOGY

IF3.3

2023-01-064

OAAI

Impact of skeletal muscle loss during conversion therapy on clinical outcomes in lavage cytology positive patients with gastric cancer

FRONTIERS IN ONCOLOGY

IF3.3

2022-09-2310

OAAI

Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours

FRONTIERS IN NUTRITION

IF5.1

2022-09-0223

OAAI

Efficacy and safety of sintilimab plus XELOX as a neoadjuvant regimen in patients with locally advanced gastric cancer: A single-arm, open-label, phase II trial

sintilimab联合XELOX作为局部晚期胃癌患者新辅助治疗方案的疗效和安全性: 单臂，开放标签，II期试验

FRONTIERS IN ONCOLOGY

IF3.3

2022-08-2631

OAAI

Combined systemic inflammatory immunity index and prognostic nutritional index scores as a screening marker for sarcopenia in patients with locally advanced gastric cancer

联合全身炎症免疫指数和预后营养指数评分作为局部晚期胃癌患者肌肉减少症的筛查指标

FRONTIERS IN NUTRITION

IF5.1

2022-08-1519

OAAI

Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery

FRONTIERS IN ONCOLOGY

IF3.3

2022-06-083

OAAI

Assessment of Carbon Nanoparticle Suspension Lymphography-Guided Distal Gastrectomy for Gastric Cancer

JAMA NETWORK OPEN

IF9.7

2022-04-1819

OAAI

Honghai Guo

个人简介

教育背景

工作经历

荣誉奖项

研究方向